Faruqi & Faruqi Investigates Soleno Investor Losses
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 22 2026
0mins
Source: PRnewswire
- Legal Investigation Launched: Faruq & Faruqi, LLP is investigating Soleno Therapeutics, focusing on investors who purchased or acquired securities between March 26, 2025, and November 4, 2025, to assess potential legal claims.
- Investor Rights Reminder: The firm reminds investors that May 5, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, emphasizing the importance of timely action to protect their rights.
- Contact Information Provided: Investors who have suffered losses are encouraged to contact Faruq & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal options.
- Securities Law Firm Role: As a leading national securities law firm, Faruq & Faruqi is committed to providing legal support to investors, ensuring their rights are upheld in securities litigation.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
